Alliant Intl. University

Topics in Prescriptive Authority (RxP) | Neuroscience and Psychopharmacology in the Era of COVID19

Neuroscience and Psychopharmacology in the Era of COVID19
The pace at which the health and financial consequences of COVID19 have pervaded society has left us in an overwhelming state of stress. Science and medicine have generated theories that normally are tested over time, but the precipitous climb of mortality and morbidity left us scrambling for answers and hanging our hopes on treatments that ultimately proved ineffective or in some cases hazardous. This presentation will parse out the scientific facts from theory regarding neurological sequelae of COVID19 exposure and how medications prescribed for mental health conditions may interact with treatments used for COVID19.

Please join us for a series of webinars exploring topics in Clinical Psychopharmacology. Our featured speaker is Dr. Judith Steinman, PhD. As past-President of APA Division 55 and Program Director for the nation’s first Postdoctoral Master of Science in Clinical Psychopharmacology, Dr. Steinman will share with you her experience in the field and the importance of prescriptive authority for improved behavioral mental health access.

Monday, October 19 at 4:00pm

Virtual Event
Event Type

Meetings & Info Sessions, Webinar

Target Audience

Alumni, General Public, Prospective Student


Academic & Research


Virtual Event

California School of Professional Psychology


Google Calendar iCal Outlook

Recent Activity

You're not going yet!

This event requires registration.